Synchron raises $75 million Series C led by ARCH Venture Partners to advance endovascular brain-computer interface

The funding will accelerate development of Synchron’s first platform product (Synchron SwitchTM BCI), and launch a pivotal clinical trial.

Related Keywords

Melbourne ,Victoria ,Australia ,Tom Oxley ,Robert Nelsen ,Shanda Group ,Reliance Digital Health ,University Of Melbourne ,Gates Frontier ,Bezos Expeditions ,Reliance Digital Health Limited ,Alumni Ventures ,Moore Strategic Ventures ,Khosla Ventures ,Neurotechnology Investors ,Forepont Capital Partners ,Managing Director Robert Nelsen ,Managing Director Robert ,Synchron Switch ,Synchron ,March Venture ,